ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026

MAPK Pathway Mutations Emerge in Mutant IDH1 Inhibitor-Resistant Cholangiocarcinoma and Attenuate the IFN Response.

Jinkai Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.